Melanie Wu1, Rita Ceponiene2, Ece Bayram1, Irene Litvan1. 1. University of California San Diego Department of Neurosciences Movement Disorders Center La Jolla California USA. 2. Southern California Physician Medical Group Kaiser Permanente San Diego California USA.
Abstract
BACKGROUND: Niemann-Pick disease type C (NPC) is a rare, autosomal recessive lysosomal lipid storage disorder. It may present with cerebellar ataxia, vertical supranuclear gaze palsy, and cognitive impairment, and the age of symptom onset in adult-onset NPC is usually earlier than the fourth decade. CASES: We present 2 patients with adult-onset NPC diagnosed in the seventh decade of life. The slow motor progression and subtle findings of supranuclear vertical gaze palsy and ataxia can lead to a delayed diagnosis and misdiagnosis with parkinsonian disorders, particularly progressive supranuclear palsy. CONCLUSION: This report highlights and differentiates key clinical characteristics between NPC and parkinsonian disorders. It is important to consider NPC in the differential diagnosis when patients present with slowed vertical saccades, vertical supranuclear gaze palsy, ataxia, and cognitive impairment present at any age. This will allow appropriate and prompt treatment with miglustat and novel experimental therapies.
BACKGROUND: Niemann-Pick disease type C (NPC) is a rare, autosomal recessive lysosomal lipid storage disorder. It may present with cerebellar ataxia, vertical supranuclear gaze palsy, and cognitive impairment, and the age of symptom onset in adult-onset NPC is usually earlier than the fourth decade. CASES: We present 2 patients with adult-onset NPC diagnosed in the seventh decade of life. The slow motor progression and subtle findings of supranuclear vertical gaze palsy and ataxia can lead to a delayed diagnosis and misdiagnosis with parkinsonian disorders, particularly progressive supranuclear palsy. CONCLUSION: This report highlights and differentiates key clinical characteristics between NPC and parkinsonian disorders. It is important to consider NPC in the differential diagnosis when patients present with slowed vertical saccades, vertical supranuclear gaze palsy, ataxia, and cognitive impairment present at any age. This will allow appropriate and prompt treatment with miglustat and novel experimental therapies.
Authors: G Trendelenburg; M T Vanier; S Maza; G Millat; G Bohner; D L Munz; R Zschenderlein Journal: J Neurol Neurosurg Psychiatry Date: 2006-08 Impact factor: 10.154
Authors: Sara Boenzi; Federica Deodato; Roberta Taurisano; Diego Martinelli; Daniela Verrigni; Rosalba Carrozzo; Enrico Bertini; Anna Pastore; Carlo Dionisi-Vici; David W Johnson Journal: Clin Chim Acta Date: 2014-07-16 Impact factor: 3.786
Authors: Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan Journal: Mov Disord Date: 2017-05-03 Impact factor: 10.338
Authors: Nikola Kresojević; Valerija Dobričić; Milica Ječmenica Lukić; Aleksandra Tomić; Igor Petrović; Nataša Dragašević; Ivana Perović; Ana Marjanović; Marija Branković; Milena Janković; Ivana Novaković; Marina Svetel; Vladimir S Kostić Journal: J Neurol Date: 2022-01-07 Impact factor: 4.849